Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Pharmaceutical Design, Volume 20 - Number 23




Serotonin 5-HT4 Receptors: A New Strategy for Developing Fast Acting Antidepressants?

, 20(23): 3751 - 3762

Rebeca Vidal, Elena Castro, Fuencisla Pilar-Cuellar, Jesus Pascual-Brazo, Alvaro Diaz, María Luisa Rojo, Raquel Linge, Alicia Martin, Elsa M. Valdizan and Angel Pazos


DOI: 10.2174/13816128113196660734



Signaling Pathways Involved in Antidepressant-Induced Cell Proliferation and Synaptic Plasticity

, 20(23): 3776 - 3794

Fuencisla Pilar-Cuellar, Rebeca Vidal, Alvaro Díaz, Elena Castro, Severiano dos Anjos, Veronica Vargas, Beatriz Romero and Elsa M. Valdizan


DOI: 10.2174/13816128113196660736






Editor-in-Chief

Alessandro Antonelli
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)
Biography
View Full Editorial Board

Executive Editor

Atta-ur-Rahman, FRS
(32052 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
(UK)
Biography

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks.
Scopus CiteScore Metrics: 2.32

Advertisement

New Year Offer 2021Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog